KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Other Non-Current Liabilities (2016 - 2025)

NovoCure's Other Non-Current Liabilities history spans 12 years, with the latest figure at $19000.0 for Q3 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 5.56% to $19000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $19000.0, a 5.56% increase, with the full-year FY2024 number at $18000.0, changed 0.0% from a year prior.
  • Other Non-Current Liabilities hit $19000.0 in Q3 2025 for NovoCure, up from $18000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for NVCR hit a ceiling of $379000.0 in Q3 2021 and a floor of $18000.0 in Q4 2023.
  • Historically, Other Non-Current Liabilities has averaged $112368.4 across 5 years, with a median of $119000.0 in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 125.6% in 2021 and later plummeted 87.84% in 2023.
  • Tracing NVCR's Other Non-Current Liabilities over 5 years: stood at $166000.0 in 2021, then decreased by 10.84% to $148000.0 in 2022, then plummeted by 87.84% to $18000.0 in 2023, then changed by 0.0% to $18000.0 in 2024, then increased by 5.56% to $19000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for NVCR at $19000.0 in Q3 2025, $18000.0 in Q2 2025, and $18000.0 in Q1 2025.